Endocrine system

Showing 1-24 of 26 item(s)

Endocrine system

Metformin XR 750mg Tablet - Glucophage XR - 1 box

P06003345

Reduction in risk or delay of onset of type 2 DM in adults, overweight patients with impaired glucose & fasting tolerance and/or increased HbA1c who are at high risk for developing overweight type 2 DM & still progressing towards type 2 DM despite implementing intensive lifestyle change for 3-6 months. Monotherapy or in combination with other oral...

View

Endocrine system

Empagliflozin + Metformin - Jardiance Duo 12.5/1000mg Tablet - 1 box

Type 2 DM as monotherapy in adults inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to intolerance. Add-on combination therapy w/ other glucose-lowering drugs eg, insulin & when diet & exercise is inappropriate. Reduction of CV death risks in patients w/ type 2 DM & established CV disease.

View

Endocrine system

Empagliflozin + Metformin - Jardiance Duo 12.5/500mg Tablet - 1 box

View

Endocrine system

Empagliflozin + Metformin - Jardiance Duo 12.5/850mg Tablet

Type 2 DM as monotherapy in adults inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to intolerance. Add-on combination therapy with other glucose-lowering drugs eg, insulin & when diet & exercise is inappropriate. Reduction of CV death risks in patients with type 2 DM & established CV disease.

View

Endocrine system

Empagliflozin + Metformin - Jardiance Duo 5/500mg Tablet - 1 box

View

Endocrine system

Empagliflozin 25mg - Jardiance - 1 box

View

Endocrine system

Empagliflozin 10mg - Jardiance - 1 box

View

Endocrine system

Sitagliptin + Metformin XR - Janumet XR 100/1000mg - 1 box

Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination with sulfonylurea, or max tolerated dose of metformin &...

View

Endocrine system

Sitagliptin + Metformin XR - Janumet XR 50/1000mg - 1 box

View

Endocrine system

Sitagliptin + Metformin XR - Janumet XR 50/500mg - 1 box

View

Endocrine system

Sitagliptin + Metformin - Janumet 50/850mg - 1 box

Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...

View

Endocrine system

Sitagliptin + Metformin - Janumet 50/1000mg - 1 box

Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...

View

Endocrine system

Sitagliptin + Metformin - Janumet 50/500mg - 1 box

Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...

View

Endocrine system

Metformin 500mg Tablet - Glumet XR - 1 box

P06002314

Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type...

View

Endocrine system

Metformin XR 1000mg Tablet - Glucophage XR - 1 box

P06003345

Reduction in risk or delay of onset of type 2 DM in adults, overweight patients with impaired glucose & fasting tolerance &/or increased HbA1c who are at high risk for developing overweight type 2 DM & still progressing towards type 2 DM despite implementing intensive lifestyle change for 3-6 months. Monotherapy or in combination with other...

View